Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABCL | CTKB | PCRX | ||
| Company | Abcellera Biologics Inc | Cytek Biosciences Inc | Pacira Pharm Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.66 | 6.20 | 17.15 | ||
| High | 2.77 | 6.54 | 17.55 | ||
| Low | 2.61 | 6.02 | 17.02 | ||
| Last | 2.72 | 6.46 | 17.38 | ||
| Change | +0.05 | +0.33 | +0.35 | ||
| % Change | +1.87% | +5.38% | +2.06% | ||
| Volume | 1,428,300 | 598,000 | 397,600 | ||
| 20-Day Average Volume | 2,561,235 | 911,420 | 562,165 | ||
| Previous Close | 2.67 | 6.13 | 17.03 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.78 | 5.99 | 16.95 | ||
| 20-Day Raw Stochastic | 32.35% | 60.61% | 58.97% | ||
| 20-Day Relative Strength | 49.61% | 58.12% | 56.21% | ||
| Weighted Alpha | -40.14 | -19.07 | +2.45 | ||
| Today's Opinion | 40% Sell | 24% Buy | 16% Sell | ||
| Previous Opinion | 56% Sell | 24% Buy | 16% Sell | ||
| Last Month's Opinion | 40% Sell | 100% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.45% since 11/14/24 | +0.62% since 11/14/24 | +6.17% since 11/14/24 | ||
| Low | 2.57 on 11/15/24 | 5.68 on 11/19/24 | 16.00 on 11/18/24 | ||
| High | 2.77 on 11/21/24 | 6.54 on 11/21/24 | 17.55 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | -1.81% since 10/21/24 | +25.68% since 10/21/24 | +0.29% since 10/21/24 | ||
| Low | 2.50 on 11/05/24 | 4.66 on 10/25/24 | 16.00 on 11/18/24 | ||
| High | 3.18 on 11/11/24 | 7.63 on 11/07/24 | 18.34 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | +3.03% since 08/21/24 | +20.07% since 08/21/24 | +25.49% since 08/21/24 | ||
| Low | 2.34 on 09/10/24 | 4.66 on 10/25/24 | 12.61 on 09/12/24 | ||
| High | 3.18 on 11/11/24 | 7.63 on 11/07/24 | 18.34 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | -29.35% since 05/21/24 | +7.31% since 05/21/24 | -43.75% since 05/21/24 | ||
| Low | 2.34 on 09/10/24 | 4.66 on 10/25/24 | 11.16 on 08/13/24 | ||
| High | 4.34 on 05/28/24 | 7.63 on 11/07/24 | 31.64 on 06/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 788,627 | 789,612 | 786,326 | ||
| Shares Outstanding, K | 295,366 | 128,811 | 46,173 | ||
| Annual Sales | 38,030,000 | 193,020,000 | 674,980,000 | ||
| Annual Net Income | -146,400,000 | -12,150,000 | 41,960,000 | ||
| Last Quarter Sales | 6,510,000 | 51,500,000 | 168,570,000 | ||
| Last Quarter Net Income | -51,110,000 | 940,000 | -143,470,000 | ||
| 60-Month Beta | 0.35 | 1.32 | 0.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 11/04/24 | 0.01 on 11/05/24 | 0.79 on 11/06/24 | ||
| Latest Earnings Date | 11/04/24 | 11/05/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 7.27 | ||